Effects of Arzoxifene on Bone Mass and the Uterus

Clinical trial NCT00085956 · COMPLETED

Trial details

NCT number: NCT00085956
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Bone Loss

Start date: 2004-04-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.